These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 37587511)

  • 61. Multifocal Cerebral Microinfarcts Modulate Early Alzheimer's Disease Pathology in a Sex-Dependent Manner.
    Lecordier S; Pons V; Rivest S; ElAli A
    Front Immunol; 2021; 12():813536. PubMed ID: 35173711
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Repopulated microglia induce expression of Cxcl13 with differential changes in Tau phosphorylation but do not impact amyloid pathology.
    Karaahmet B; Le L; Mendes MS; Majewska AK; O'Banion MK
    J Neuroinflammation; 2022 Jul; 19(1):173. PubMed ID: 35787714
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Aβ promotes CD38 expression in senescent microglia in Alzheimer's disease.
    Hu Y; Huang Y; Xing S; Chen C; Shen D; Chen J
    Biol Res; 2022 Mar; 55(1):10. PubMed ID: 35241173
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Microglial heterogeneity in aging and Alzheimer's disease: Is sex relevant?
    Delage CI; Šimončičová E; Tremblay MÈ
    J Pharmacol Sci; 2021 Jul; 146(3):169-181. PubMed ID: 34030799
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease.
    Boza-Serrano A; Ruiz R; Sanchez-Varo R; García-Revilla J; Yang Y; Jimenez-Ferrer I; Paulus A; Wennström M; Vilalta A; Allendorf D; Davila JC; Stegmayr J; Jiménez S; Roca-Ceballos MA; Navarro-Garrido V; Swanberg M; Hsieh CL; Real LM; Englund E; Linse S; Leffler H; Nilsson UJ; Brown GC; Gutierrez A; Vitorica J; Venero JL; Deierborg T
    Acta Neuropathol; 2019 Aug; 138(2):251-273. PubMed ID: 31006066
    [TBL] [Abstract][Full Text] [Related]  

  • 66. TREM2 Alzheimer's variant R47H causes similar transcriptional dysregulation to knockout, yet only subtle functional phenotypes in human iPSC-derived macrophages.
    Hall-Roberts H; Agarwal D; Obst J; Smith TB; Monzón-Sandoval J; Di Daniel E; Webber C; James WS; Mead E; Davis JB; Cowley SA
    Alzheimers Res Ther; 2020 Nov; 12(1):151. PubMed ID: 33198789
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evolution of neuroinflammation across the lifespan of individuals with Down syndrome.
    Flores-Aguilar L; Iulita MF; Kovecses O; Torres MD; Levi SM; Zhang Y; Askenazi M; Wisniewski T; Busciglio J; Cuello AC
    Brain; 2020 Dec; 143(12):3653-3671. PubMed ID: 33206953
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Human microglia show unique transcriptional changes in Alzheimer's disease.
    Prater KE; Green KJ; Mamde S; Sun W; Cochoit A; Smith CL; Chiou KL; Heath L; Rose SE; Wiley J; Keene CD; Kwon RY; Snyder-Mackler N; Blue EE; Logsdon B; Young JE; Shojaie A; Garden GA; Jayadev S
    Nat Aging; 2023 Jul; 3(7):894-907. PubMed ID: 37248328
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Transcriptomic analysis of the hippocampus from six inbred strains of mice suggests a basis for sex-specific susceptibility and severity of neurological disorders.
    Vied C; Ray S; Badger CD; Bundy JL; Arbeitman MN; Nowakowski RS
    J Comp Neurol; 2016 Sep; 524(13):2696-710. PubMed ID: 26917114
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treadmill exercise improve recognition memory by TREM2 pathway to inhibit hippocampal microglial activation and neuroinflammation in Alzheimer's disease model.
    Zhang L; Liu Y; Wang X; Wang D; Wu H; Chen H; Chen J; Liu Y
    Physiol Behav; 2022 Jul; 251():113820. PubMed ID: 35452628
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Functional and Phenotypic Diversity of Microglia: Implication for Microglia-Based Therapies for Alzheimer's Disease.
    Xu YJ; Au NPB; Ma CHE
    Front Aging Neurosci; 2022; 14():896852. PubMed ID: 35693341
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mechanism of TREM2/DAP12 complex affecting β-amyloid plaque deposition in Alzheimer's disease modeled mice through mediating inflammatory response.
    Cui X; Qiao J; Liu S; Wu M; Gu W
    Brain Res Bull; 2021 Jan; 166():21-28. PubMed ID: 33053435
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Targeting Microglia in Alzheimer's Disease: From Molecular Mechanisms to Potential Therapeutic Targets for Small Molecules.
    Althafar ZM
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807370
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Reduced TREM2 activation in microglia of patients with Alzheimer's disease.
    Okuzono Y; Sakuma H; Miyakawa S; Ifuku M; Lee J; Das D; Banerjee A; Zhao Y; Yamamoto K; Ando T; Sato S
    FEBS Open Bio; 2021 Nov; 11(11):3063-3080. PubMed ID: 34523252
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Higher levels of kallikrein-8 in female brain may increase the risk for Alzheimer's disease.
    Keyvani K; Münster Y; Kurapati NK; Rubach S; Schönborn A; Kocakavuk E; Karout M; Hammesfahr P; Wang YC; Hermann DM; Teuber-Hanselmann S; Herring A
    Brain Pathol; 2018 Nov; 28(6):947-964. PubMed ID: 29505099
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.
    Hernandez MX; Jiang S; Cole TA; Chu SH; Fonseca MI; Fang MJ; Hohsfield LA; Torres MD; Green KN; Wetsel RA; Mortazavi A; Tenner AJ
    Mol Neurodegener; 2017 Sep; 12(1):66. PubMed ID: 28923083
    [TBL] [Abstract][Full Text] [Related]  

  • 77. PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer's disease.
    Tsai AP; Dong C; Lin PB; Messenger EJ; Casali BT; Moutinho M; Liu Y; Oblak AL; Lamb BT; Landreth GE; Bissel SJ; Nho K
    Genome Med; 2022 Feb; 14(1):17. PubMed ID: 35180881
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ultrastructural characterization of dark microglia during aging in a mouse model of Alzheimer's disease pathology and in human post-mortem brain samples.
    St-Pierre MK; Carrier M; González Ibáñez F; Šimončičová E; Wallman MJ; Vallières L; Parent M; Tremblay MÈ
    J Neuroinflammation; 2022 Sep; 19(1):235. PubMed ID: 36167544
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Disease-related microglia heterogeneity in the hippocampus of Alzheimer's disease, dementia with Lewy bodies, and hippocampal sclerosis of aging.
    Bachstetter AD; Van Eldik LJ; Schmitt FA; Neltner JH; Ighodaro ET; Webster SJ; Patel E; Abner EL; Kryscio RJ; Nelson PT
    Acta Neuropathol Commun; 2015 May; 3():32. PubMed ID: 26001591
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer's disease.
    McQuade A; Kang YJ; Hasselmann J; Jairaman A; Sotelo A; Coburn M; Shabestari SK; Chadarevian JP; Fote G; Tu CH; Danhash E; Silva J; Martinez E; Cotman C; Prieto GA; Thompson LM; Steffan JS; Smith I; Davtyan H; Cahalan M; Cho H; Blurton-Jones M
    Nat Commun; 2020 Oct; 11(1):5370. PubMed ID: 33097708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.